CRL on the prowl for Chinese M&As in world’s future science hub
Charles River Labs (CRL) has singled out China as an area of “disproportionate growth” in biologics R&D and says it is on the hunt for preclinical acquisitions in the region.
Archives for September 15, 2014
Biosimilar mAbs to cut Europe's healthcare bill by €20bn by 2020
At present Biosimilars save Europe roughly €2.40 per person, or €1.8bn a year, but by 2020 follow-on mAbs alone will shave €20bn off the continent’s healthcare bill according to researchers.
Roche: Counterfeit MabThera discovered in Germany
A German parallel importer has informed Roche that counterfeit versions of its cancer treatment MabThera (rituximab) have been discovered in Germany.